Bastion Therapeutics is a preclinical stage biotechnology company with a mission to develop novel Treg therapies to address the unmet clinical need for inflammatory disorders. 

We leverage our proprietary GRIT™ platform technology to enhance Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg therapies. 

Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. 

Biotechnology

Life Sciences

Bastion Therapeutics

Bastion Therapeutics' headquarters in London, United Kingdom

Description

People (1)

Nia Emami

Jobs